Microbiotica
Microbiotica develops oral medicines made from selected live bacteria for inflammatory diseases and cancer treatment.
£36MSeries C first close
LeadBB
British Business Bank
Activity from announced rounds
All recorded activity
British Business Bank is the UK’s economic development bank, supporting business access to finance through investment programmes, funds and financing partners.
Its Future Fund: Breakthrough programme, delivered by British Patient Capital, co-invests with private investors in later-stage, R&D-intensive UK companies. It targets technologies such as quantum computing, cleantech and life sciences, where development requires substantial capital.
Applications to that programme come from a qualifying sponsor investor, rather than directly from the company. The published criteria require a round of at least £30 million, with the programme contributing no more than 30% on the sponsor investor’s terms.
- Rounds participated in
- 17
- Confirmed lead rounds
- 2 12 roles undisclosed
- New companies
- 17 First participation on record · 0 follow-on
- Funding in participating rounds
- $3B 15 disclosed · full round size, not this investor’s share
By stage
By primary sector
3 more
Fintech1
Healthtech1
Space tech1
By country
Rounds
17 in all activityOMass Therapeutics
OMass Therapeutics develops small-molecule medicines for endocrine and immune diseases using a platform that measures drug targets in their biological surroundings.
$310MSeries C
ParticipantSalience Labs
Salience Labs develops silicon photonic switches for datacenter operators connecting large AI computing clusters.
$125MSeries B
ParticipantCSignum
CSignum makes wireless communications technology that lets IoT sensors transmit data from underwater and underground infrastructure without conventional cable runs.
£2.6MFollow-on funding
ParticipantCertain Energy
Certain Energy develops hydrogen-manganese flow batteries to help electricity grids and renewable generators store power for periods of low wind and solar output.
£10MSeries A
LeadDraig Therapeutics
Draig Therapeutics develops neuropsychiatric medicines.
$65MSeries B
Role not disclosedOxford Quantum Circuits
Develops superconducting quantum computers delivered via cloud for financial services, defence, and research customers
£260MSeries C
Role not disclosedIMU Biosciences
Profiles human immune systems using multi-omic analysis and machine learning for disease research.
$53MSeries A
Role not disclosedElliptic
Provides on-chain analytics for digital assets
$120MSeries D
Role not disclosedQuantum Motion
Builds utility-scale quantum computers using industry-standard silicon transistors
$160MSeries C
Role not disclosedHadean
Develops AI-powered digital wargaming and command-and-control capabilities.
UndisclosedUndisclosed
Role not disclosedWayve
Provides end-to-end AI platform for autonomous driving licensed to automakers and mobility platforms
$1.5BSeries D
Role not disclosedPontiro
Enables safe and compliant use of medical imaging data for research and AI
£357KSeed
Role not disclosedSatVu
Provides space-based thermal intelligence data for defense security and infrastructure monitoring
£30MSeries A
Role not disclosedTenpoint Therapeutics
Develops treatments to rejuvenate vision in the aging eye
$235MSeries B
Role not disclosedKraken Technologies
Kraken leverages AI to automate customer service and billing for energy firms
£25MUndisclosed
Role not disclosedNuclera
Provides rapid access to functional proteins through benchtop eProtein Discovery System
$12MSeries C+
Role not disclosed